N DAVID EANSOR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for N DAVID EANSOR.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of N DAVID EANSOR. N DAVID EANSOR is a in CAMBREX CORP ($CBM) and a President-Protein Sciences in BIO-TECHNE Corp ($TECH) and a SVP - Biotech in BIO-TECHNE Corp ($TECH) and a SVP - Novus Biologicals in BIO-TECHNE Corp ($TECH) and a SVP Biotech in BIO-TECHNE Corp ($TECH) and a Director in Marker Therapeutics, Inc. ($TPIV).
Address: ONE MEADOWLANDS PLAZA EAST RUTHERFORD 07073 NJ
Companies in which N DAVID EANSOR is an Insider
BIO-TECHNE Corp
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of N DAVID EANSOR: President-Protein Sciences, SVP - Biotech, SVP - Novus Biologicals, SVP Biotech
Holdings: 15,432 shares
Current Value: $1,561,410
Latest Transaction: Feb 09 2021
$TECH Market Capitalization: $3.73B
$TECH Previous Close: $101.18
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CAMBREX CORP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of N DAVID EANSOR:
Holdings: 6,298 shares
Current Value: $345,130
Latest Transaction: Jan 06 2006
$CBM Market Capitalization: $1.70B
$CBM Previous Close: $54.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Marker Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of N DAVID EANSOR: Director
Holdings: 36,940 shares
Current Value: $164,383
Latest Transaction: Jun 10 2021
$MRKR Market Capitalization: $36.11M
$MRKR Previous Close: $4.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of N DAVID EANSOR
Sentiment: All, TECH, CBM, MRKR
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 10 2021 | MRKR | Marker Therapeutic ... | Eansor Norman David | Director | Grant | A | 0.00 | 12,658 | 0 | 36,940 | 24.3 K to 36.9 K (+52.13 %) |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 18,819 | 2,005,917 | 0 | |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Option Exercise | M | 106.59 | 14,114 | 1,504,411 | 0 | |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 385.59 | 1,100 | 424,151 | 1,318 | 2.4 K to 1.3 K (-45.49 %) |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 384.15 | 1,900 | 729,888 | 2,418 | 4.3 K to 2.4 K (-44.00 %) |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 382.60 | 3,700 | 1,415,636 | 4,318 | 8 K to 4.3 K (-46.15 %) |
| Feb 09 2021 | TECH | BIO-TECHNE Corp | Eansor Norman David | President-Protein S ... | Sell | S | 381.52 | 2,900 | 1,106,395 | 8,018 | 10.9 K to 8 K (-26.56 %) |